These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 23161364)
1. p53 acetylation enhances Taxol-induced apoptosis in human cancer cells. Kim JH; Yoon EK; Chung HJ; Park SY; Hong KM; Lee CH; Lee YS; Choi K; Yang Y; Kim K; Kim IH Apoptosis; 2013 Jan; 18(1):110-20. PubMed ID: 23161364 [TBL] [Abstract][Full Text] [Related]
2. Induction of PIG3 and NOXA through acetylation of p53 at 320 and 373 lysine residues as a mechanism for apoptotic cell death by histone deacetylase inhibitors. Terui T; Murakami K; Takimoto R; Takahashi M; Takada K; Murakami T; Minami S; Matsunaga T; Takayama T; Kato J; Niitsu Y Cancer Res; 2003 Dec; 63(24):8948-54. PubMed ID: 14695212 [TBL] [Abstract][Full Text] [Related]
3. The histone deacetylase inhibitor trichostatin A induces cell cycle arrest and apoptosis in colorectal cancer cells via p53-dependent and -independent pathways. Meng J; Zhang HH; Zhou CX; Li C; Zhang F; Mei QB Oncol Rep; 2012 Jul; 28(1):384-8. PubMed ID: 22552631 [TBL] [Abstract][Full Text] [Related]
4. Survivin deregulation in beta-tubulin mutant ovarian cancer cells underlies their compromised mitotic response to taxol. Zhou J; O'brate A; Zelnak A; Giannakakou P Cancer Res; 2004 Dec; 64(23):8708-14. PubMed ID: 15574781 [TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibitors differentially stabilize acetylated p53 and induce cell cycle arrest or apoptosis in prostate cancer cells. Roy S; Packman K; Jeffrey R; Tenniswood M Cell Death Differ; 2005 May; 12(5):482-91. PubMed ID: 15746940 [TBL] [Abstract][Full Text] [Related]
6. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer. Shi YK; Li ZH; Han XQ; Yi JH; Wang ZH; Hou JL; Feng CR; Fang QH; Wang HH; Zhang PF; Wang FS; Shen J; Wang P Cancer Chemother Pharmacol; 2010 Nov; 66(6):1131-40. PubMed ID: 20838997 [TBL] [Abstract][Full Text] [Related]
7. DNA methyltransferase inhibition enhances apoptosis induced by histone deacetylase inhibitors. Zhu WG; Lakshmanan RR; Beal MD; Otterson GA Cancer Res; 2001 Feb; 61(4):1327-33. PubMed ID: 11245429 [TBL] [Abstract][Full Text] [Related]
8. Disruption of p53 function in immortalized human cells does not affect survival or apoptosis after taxol or vincristine treatment. Fan S; Cherney B; Reinhold W; Rucker K; O'Connor PM Clin Cancer Res; 1998 Apr; 4(4):1047-54. PubMed ID: 9563901 [TBL] [Abstract][Full Text] [Related]
9. HDAC inhibitor DWP0016 activates p53 transcription and acetylation to inhibit cell growth in U251 glioblastoma cells. Jin H; Liang L; Liu L; Deng W; Liu J J Cell Biochem; 2013 Jul; 114(7):1498-509. PubMed ID: 23297003 [TBL] [Abstract][Full Text] [Related]
10. Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1). Zhao Y; Lu S; Wu L; Chai G; Wang H; Chen Y; Sun J; Yu Y; Zhou W; Zheng Q; Wu M; Otterson GA; Zhu WG Mol Cell Biol; 2006 Apr; 26(7):2782-90. PubMed ID: 16537920 [TBL] [Abstract][Full Text] [Related]
11. Oxaliplatin, a potent inhibitor of survivin, enhances paclitaxel-induced apoptosis and mitotic catastrophe in colon cancer cells. Fujie Y; Yamamoto H; Ngan CY; Takagi A; Hayashi T; Suzuki R; Ezumi K; Takemasa I; Ikeda M; Sekimoto M; Matsuura N; Monden M Jpn J Clin Oncol; 2005 Aug; 35(8):453-63. PubMed ID: 16024531 [TBL] [Abstract][Full Text] [Related]
12. Phosphorylated and hypoacetylated mutant p53 enhances cisplatin-induced apoptosis through caspase-9 pathway in the absence of transcriptional activation or translation. Lai MD; Lin WC; Sun YM; Chang FL Int J Mol Med; 2005 Apr; 15(4):725-34. PubMed ID: 15754039 [TBL] [Abstract][Full Text] [Related]
13. Taxol-induced growth arrest and apoptosis is associated with the upregulation of the Cdk inhibitor, p21WAF1/CIP1, in human breast cancer cells. Choi YH; Yoo YH Oncol Rep; 2012 Dec; 28(6):2163-9. PubMed ID: 23023313 [TBL] [Abstract][Full Text] [Related]
15. Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer. Shankar S; Srivastava RK Int J Oncol; 2007 Apr; 30(4):905-18. PubMed ID: 17332930 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the antitumor efficacy, pharmacokinetics, and pharmacodynamics of the histone deacetylase inhibitor depsipeptide in childhood cancer models in vivo. Graham C; Tucker C; Creech J; Favours E; Billups CA; Liu T; Fouladi M; Freeman BB; Stewart CF; Houghton PJ Clin Cancer Res; 2006 Jan; 12(1):223-34. PubMed ID: 16397046 [TBL] [Abstract][Full Text] [Related]
17. Increased p53 phosphorylation after microtubule disruption is mediated in a microtubule inhibitor- and cell-specific manner. Stewart ZA; Tang LJ; Pietenpol JA Oncogene; 2001 Jan; 20(1):113-24. PubMed ID: 11244509 [TBL] [Abstract][Full Text] [Related]
18. Taxol induction of p21WAF1 and p53 requires c-raf-1. Blagosklonny MV; Schulte TW; Nguyen P; Mimnaugh EG; Trepel J; Neckers L Cancer Res; 1995 Oct; 55(20):4623-6. PubMed ID: 7553639 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms of Taxol-induced cell death are concentration dependent. Torres K; Horwitz SB Cancer Res; 1998 Aug; 58(16):3620-6. PubMed ID: 9721870 [TBL] [Abstract][Full Text] [Related]
20. Id-1 regulates Bcl-2 and Bax expression through p53 and NF-kappaB in MCF-7 breast cancer cells. Kim H; Chung H; Kim HJ; Lee JY; Oh MY; Kim Y; Kong G Breast Cancer Res Treat; 2008 Nov; 112(2):287-96. PubMed ID: 18158619 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]